ROVI Pharmaceutical Company

ROVI Pharmaceutical Company is a pan‑European pharmaceutical firm focused on the research, development, licensed manufacturing, and commercialization of small‑molecule drugs and biologic specialties. The company operates through subsidiaries in Portugal, Germany, the United Kingdom, Italy, France, and Austria, supporting a diversified portfolio of more than 40 marketed products. ROVI’s flagship product, Bemiparin, is sold in 60 countries, and its internally developed enoxaparin biosimilar is also available across Europe and roughly 60 global markets. The company continues to advance its proprietary ISM® platform, a cutting‑edge technology for extended‑release drug delivery that enhances therapeutic efficacy and patient compliance.